#Succinate

[wikipediapictures]

Riboflavin

“Micrococcus luteus (ATCC strain number 49442) develops a yellow color due to production of riboflavin while growing on pyridine but not when grown on other substrates, such as succinic acid.” - via Wikimedia Commons

[surajjhaseo]

Latest Sodium Succinate Manufacturing Plant Project Report by Procurement Resource

Procurement Resource, a leading provider of procurement intelligence and market research solutions, has launched its latest Sodium Succinate Manufacturing Report. This detailed report provides a comprehensive roadmap for entrepreneurs and enterprises aiming to establish a successful sodium succinate manufacturing unit, offering critical insights into industry trends, plant setup, machinery requirements, cost structures, and investment opportunities.

Sodium Succinate: A Versatile Food and Pharmaceutical Additive

Sodium succinate is a water-soluble sodium salt of succinic acid with the chemical formula C₄H₄Na₂O₄. It serves a wide range of applications across food, pharmaceutical, and chemical industries due to its buffering capacity, flavor-enhancing properties, and role as an intermediate in biosynthetic processes. Sodium succinate is commonly used as a flavoring agent, acidity regulator, and as a component in injectable drugs and nutritional supplements. The rising demand for functional food ingredients and pharmaceutical excipients is fueling significant market growth.

Exhaustive Manufacturing Plant Report for Business Success

The Procurement Resource report delivers a meticulous breakdown of all the critical components involved in setting up a sodium succinate production facility, enabling stakeholders to make informed, strategic decisions. Key areas covered include:

Market Analysis:

Industry trends, market segmentation, and geographical performance

Price evaluation of raw materials and finished goods

Influence of regulatory norms, sustainability trends, and industry dynamics

Technical and Operational Insights:

Step-by-step sodium succinate production process

Equipment and machinery specifications (Manual/Semi-automatic/Automatic)

Infrastructure requirements, utility demands, and manpower planning

Quality control protocols and regulatory compliance

Financial and Economic Assessment:

Capital investment estimation and ongoing operational costs

Revenue forecasts, profitability analysis, and ROI calculations

Break-even evaluation and long-term financial planning strategies

Sustainability and Market Trends

The growing consumer and industrial shift toward bio-based chemicals and clean-label ingredients is driving the adoption of sodium succinate across diverse applications. With rising awareness about food safety and pharmaceutical quality, demand is expected to rise steadily, especially across Asia-Pacific, owing to rapid expansion in food processing and healthcare sectors. Innovations in green chemistry and fermentation-based production methods are opening new avenues for sustainable growth.

Why Choose Procurement Resource?

Backed by a team of seasoned analysts and domain experts, Procurement Resource delivers precise, up-to-date data to support procurement and strategic business decisions. The company specializes in:

Industry cost modeling and price trend analysis

Market research and forecasting

Comprehensive supply chain and production process analysis

Real-time data solutions for procurement teams and business planners

Check out my latest social media article and industry report:-

https://manufacturing-reports.hashnode.dev/2-chlorobenzoic-acid-manufacturing-report

https://www.linkedin.com/pulse/latest-sodium-methoxide-manufacturing-plant-project-report-suraj-jha-urzuc

Get a Free Copy of the Report

Businesses, manufacturers, and investors seeking detailed insights into the Sodium Succinate Manufacturing Plant setup will find Procurement Resource’s comprehensive report to be an indispensable tool for building a successful and future-ready operation.

Request a Free Sample Report:  https://www.procurementresource.com/reports/sodium-succinate-manufacturing-plant-project-report/request-sample

About Procurement Resource

Procurement Resource empowers clients with actionable procurement and market intelligence to stay competitive in fast-evolving industries. With deep research methodologies and access to an extensive global database, the company offers services including:

Multi-sector cost and pricing intelligence

Industry benchmarking and feasibility analysis

Production and supply chain insights

Tailored data tools to drive performance and profitability

Contact Information

Company Name: Procurement Resource Contact Person: Ashish Sharma (Sales Representative) Email: sales@procurementresource.com Location: 30 North Gould Street, Sheridan, WY 82801, USA Phone: UK: +44 7537171117 USA: +1 307 363 1045 Asia-Pacific (APAC): +91 8850629517

[deadlincs]

okay last thing ☝🏼 if anyone would like to indulge me with more things in higu’s incubus/succubus verse or nana’s siren verse specifically … i’d honk 2 the moon or whatever

[mindblowingscience]

A bacterium that can degrade the common polymer polybutylene succinate (PBS), which naturally biodegrades only to a limited extent in marine environments, could lead to improved ways to recycle this polymer. The bacterium's potential, and its enzyme molecule that breaks down PBS, were discovered by researchers at Hokkaido University, working with colleagues at the Mitsubishi Chemical Group in Japan. The team published their results in the journal��Environmental Microbiology. PBS is generally regarded as an eco-friendly polymer due to its biodegradability when discarded on land and exposed to the atmosphere. This has led to its increased use since the early 1990s in industrial plastics, including mulching films, compostable bags, and catering packaging. But many discarded plastics eventually find their way into the sea, and unfortunately, PBS does not biodegrade well in that environment.

Continue Reading.

[captainobis-stressball]

I like yaoi I guess but I LOVE yuri…I absolutely adore Girls Love. But I can’t help but notice everybody’s in their fujoshi bag it’s kind of annoying. No matter where I look in media the mlm content quadruples the wlw content it’s so lame.

Literally it’s just—

Yuri smut: like 200 works maybe

Yaoi smut: 77635828836355+

Y’all somehow even managed to make it boring/heteronormative too like you really wanna see the same exact fem twink x masc bear/seme x uke formula every single time?? 💀

Where the fuck are the lesbians??? 😭

[tightjeansjavi]

🕯️🔮✨ I WILL FINISH THIS CHAPTER AND IT WILL BE FUCKING AMAZING🕯️🔮✨

[my-innermost-musings]

What kind of angle do you like

I’m not sure what this means?

[siddhisutarwala]

Poly(butylene succinate) Market, Global Outlook and Forecast 2025-2032

Global Poly(butylene succinate) (PBS) Market continues to demonstrate sustainable growth, with its valuation reaching USD 49 million in 2023. According to the latest industry analysis, the market is projected to grow at a CAGR of 4.90%, reaching approximately USD 68.49 million by 2030.

Get Full Report Here: https://www.24chemicalresearch.com/reports/287579/global-poly-forecast-market-2025-2032-749

[dolphinpharmamanufacturer]

Best Fenofibrate Succinate Manufacturer in India

In the pharmaceutical industry, quality, consistency, and trust define the value of a manufacturer. When it comes to critical cardiovascular drugs like Fenofibrate Succinate, choosing a reliable partner is vital. If you're looking for the best Fenofibrate Succinate manufacturer in India, Dolphin Pharmaceutical stands out as a leader known for delivering excellence in every molecule.

What is Fenofibrate Succinate?

Fenofibrate Succinate is a derivative of fenofibrate, widely used to reduce bad cholesterol (LDL) and triglycerides while increasing good cholesterol (HDL). It is typically prescribed for patients with hyperlipidemia and mixed dyslipidemia. Its effectiveness and tolerability make it a go-to option in cardiovascular care.

As it plays a key role in managing long-term heart health, the manufacturing of this drug requires strict adherence to pharmaceutical standards and precision.

Dolphin Pharmaceutical – Trusted Quality for a Healthier Tomorrow

Dolphin Pharmaceutical is an established pharmaceutical drug manufacturer in India, known for high-quality Active Pharmaceutical Ingredients (APIs). Our state-of-the-art facilities, trained personnel, and global compliance certifications make us a preferred source for Fenofibrate Succinate.

We are committed to delivering superior products with consistent efficacy, making healthcare safer and more reliable worldwide.

Why We Are the Best Fenofibrate Succinate Manufacturer in India

Advanced Manufacturing Facilities

We operate WHO-GMP and ISO-certified plants equipped with cutting-edge technology, ensuring top-tier product quality and safety.

Quality & Compliance

Every batch of Fenofibrate Succinate is manufactured under strict quality protocols, tested for purity, potency, and stability.

Global Regulatory Support

We offer full documentation including DMFs, MSDS, COAs, and other essential certificates for international compliance.

Flexible Supply

From small-scale R&D batches to large commercial production, we support flexible volumes with timely delivery and competitive pricing.

Sustainability Focus

We follow eco-conscious manufacturing practices to reduce environmental impact while maintaining product integrity.

Uses of Fenofibrate Succinate

Treats high cholesterol and triglyceride levels

Reduces risk of pancreatitis in patients with extremely high triglycerides

Used as part of a comprehensive cardiovascular risk management strategy

Due to its chronic use, maintaining quality and availability is essential—Dolphin Pharmaceutical ensures both.

Why Choose a Pharmaceutical Drug Manufacturer in India?

India has become a global powerhouse in pharmaceutical manufacturing due to its advanced infrastructure, regulatory adherence, and cost-effective production. Partnering with a trusted pharmaceutical drug manufacturer in India like Dolphin Pharmaceutical brings you:

Reliable quality at competitive pricing

Timely delivery across global markets

Transparent and ethical business practices

Proven track record in supplying top pharmaceutical brands

Global Reach, Local Expertise

We export Fenofibrate Succinate and other APIs to key international markets, including the USA, Europe, Latin America, Southeast Asia, and Africa. Our strong logistics network and responsive customer service ensure your orders are fulfilled smoothly and professionally.

Partner with Dolphin Pharmaceutical

As the best Fenofibrate Succinate manufacturer in India, we take pride in our dedication to innovation, regulatory compliance, and customer satisfaction. Whether you’re a formulator, distributor, or research organization, Dolphin Pharmaceutical offers you a dependable API partnership that supports your growth and enhances your product line.

Final Thoughts

With increasing demand for effective lipid-lowering drugs, quality API suppliers play a critical role in global healthcare. Dolphin Pharmaceutical is proud to be at the forefront of this mission—delivering excellence with every shipment.

Get in touch today to request samples, regulatory files, or a custom quotation. Your trusted pharmaceutical drug manufacturer in India is just a call or click away.

[chemanalystdata]

Metoprolol Succinate Prices Index: Market Analysis, Trend, News, Graph and Demand

In the first quarter of 2025, the global Metoprolol Succinate market experienced a pronounced upward trajectory in prices, influenced by a combination of supply chain disruptions, evolving trade dynamics, and steady demand from the pharmaceutical sector. This cardiovascular drug, widely prescribed for hypertension, angina, and heart failure, has remained a staple in both developed and emerging healthcare systems. Its high clinical relevance ensures persistent demand, which in turn sensitizes the market to fluctuations in production capacity, regulatory policy, and international trade conditions. As the quarter progressed, pricing dynamics across major regions—North America, Asia Pacific, and Europe—demonstrated strong interdependence shaped by geopolitical tensions, currency fluctuations, and shifting manufacturing patterns.

In North America, the United States market for Metoprolol Succinate witnessed a consistent increase in prices throughout Q1 2025. The initial price movements in January were relatively modest, driven primarily by anticipatory purchasing ahead of the U.S. government’s imposition of a 10% tariff on pharmaceutical imports from China, effective February 1. Importers rushed to front-load inventories, creating a temporary spike in demand. This surge coincided with seasonal demand increases linked to the Chinese Lunar New Year, along with rising operational costs associated with energy and labor. Additionally, logistical hurdles in California—caused by wildfire-related labor shortages and storm-driven port congestion—further tightened the market by extending dwell times and elevating freight expenses. As a result, the market entered February with constrained inventory and heightened landed costs.

Get Real time Prices for Metoprolol Succinate: https://www.chemanalyst.com/Pricing-data/metoprolol-succinate-1455

February marked a more accelerated phase of price increases in the U.S. market, triggered by the actual implementation of the 10% tariff. This new trade policy raised procurement costs, forcing suppliers and distributors to adjust prices upward to preserve margins. Simultaneously, export prices from China, the dominant global supplier of Metoprolol Succinate, surged due to higher raw material costs and persistent international demand. With supply conditions already strained and replenishment cycles disrupted, U.S. buyers faced greater competition and limited availability. The situation was further complicated by improving consumer confidence and a resurgence in industrial activity, which indirectly supported greater pharmaceutical consumption and increased inventory drawdowns.

By March, the pricing landscape became more complex as China responded to U.S. tariffs by raising its own retaliatory tariff to a steep 125% on select pharmaceutical categories, including Metoprolol Succinate. This move had a direct impact on sourcing costs, further tightening the global supply pipeline. While logistics rates showed marginal signs of easing, the overall cost of acquisition remained elevated due to persistent inflation in raw material inputs such as active pharmaceutical ingredients (APIs) and excipients. Buyers across the U.S. adopted strategic inventory planning approaches to mitigate future risks, engaging in proactive procurement despite elevated prices. This cautious optimism and forward-buying behavior contributed to sustained upward pressure on prices throughout the end of the quarter.

In the Asia Pacific region, particularly China, Metoprolol Succinate prices also trended upward throughout the first three months of 2025. January started with modest gains, primarily attributed to seasonal slowdowns in manufacturing ahead of the Lunar New Year. Reduced production levels, when combined with steady offtake from domestic and international buyers, created localized tightness in supply. Moreover, exporters expedited shipments to the U.S. in anticipation of the upcoming tariff, which led to temporary dips in domestic availability and moderate price hikes. The overall sentiment remained cautiously bullish as traders anticipated stronger demand post-holiday.

February ushered in a more pronounced phase of price escalation as inventories tightened and raw material costs continued to rise. The U.S. tariff implementation triggered a fresh wave of international procurement, particularly from Western markets, leading to bulk orders that strained the supply chain. Meanwhile, China's manufacturing sector showed signs of recovery, reflected in a rebound of its Purchasing Managers’ Index (PMI). This resurgence in industrial activity helped restore output levels but also drove up demand for intermediate goods and active ingredients, adding to the cost pressure. Exporters responded by adjusting prices to reflect both domestic inflation and elevated global demand.

March saw a continuation and amplification of this trend as the retaliatory tariff by China spurred aggressive overseas buying, especially from markets anticipating further trade restrictions. As inventory levels declined and the cost of raw materials climbed, Chinese suppliers increased export prices significantly. Despite the benefit of reduced freight rates, the cumulative effect of these factors ensured that Metoprolol Succinate prices in the Asia Pacific remained elevated through the quarter’s end. The bullish sentiment was reinforced by the PMI reaching 50.5, signaling robust industrial output and contributing to an overall firm pricing environment.

Europe, particularly Germany, experienced a more gradual yet steady rise in Metoprolol Succinate prices during Q1 2025. The region benefited from relatively stable downstream demand and efficient inventory management at the outset of the year. In January, minor price increases were recorded amid improving economic sentiment, modest pharmaceutical production gains, and slight delays caused by Lunar New Year-induced supply adjustments. Despite minor logistics disturbances due to Red Sea transit issues, existing inventories helped maintain market balance.

In February, prices edged higher as a depreciating euro increased the cost of imports, particularly from China. Limited domestic production capacity and firm Chinese export prices added pressure, while softening freight costs provided only partial relief. Pharmaceutical demand remained consistent, driven by stable consumption patterns and proactive procurement strategies. By March, stronger economic indicators in Germany, such as an improving Manufacturing PMI and declining inflation, supported increased pharmaceutical activity. With Chinese export prices rising further, European importers faced higher acquisition costs. Despite currency fluctuations and market uncertainties, the overall trend in Europe remained upward, with prices bolstered by consistent demand and persistent cost-side inflation.

Overall, the global Metoprolol Succinate market in Q1 2025 was characterized by sustained price increases driven by a complex interplay of trade barriers, supply chain disruptions, and firm end-use demand. With geopolitical tensions escalating and raw material costs remaining high, the market is expected to retain its volatility, keeping buyers and suppliers vigilant in their sourcing and pricing strategies.

Get Real time Prices for Metoprolol Succinate: https://www.chemanalyst.com/Pricing-data/metoprolol-succinate-1455

Contact Us:

ChemAnalyst

GmbH - S-01, 2.floor, Subbelrather Straße,

15a Cologne, 50823, Germany

Call: +49-221-6505-8833

Email: sales@chemanalyst.com

Website: https://www.chemanalyst.com

[datastring]

Hydrocortisone Sodium Succinate Market set to hit $1541.4 million by 2035

Industry revenue for Hydrocortisone Sodium Succinate is estimated to rise to $1541.4 million by 2035 from $688.6 million of 2024. The revenue growth of market players is expected to average at 7.6% annually for the period 2024 to 2035.

Detailed Analysis - https://datastringconsulting.com/industry-analysis/hydrocortisone-sodium-succinate-market-research-report

Hydrocortisone Sodium Succinate is critical across several key applications including adrenal insufficiency treatment, skin inflammation management, septic shock therapy and respiratory disorder treatment. The report unwinds growth & revenue expansion opportunities at Hydrocortisone Sodium Succinate’s Product Type, Disorders, Distribution Channel, Application Area and End-Users including industry revenue forecast.

Industry Leadership and Competitive Landscape

The Hydrocortisone Sodium Succinate market is characterized by intense competition, with a number of leading players such as Pfizer Inc., Fresenius Kabi AG, Neon Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Shandong Tianxin Pharmaceutical Co. Ltd, Symbiotec Pharmalab Pvt. Ltd., Chengdu Diao Jiuhong Pharmaceutical Factory, Shanghai General Pharmaceutical Co. Ltd, Jilin Huakang Pharmaceutical Co. Ltd, Hubei Ocean Biotech Co. Ltd, Wuhan DKY Technology Co. Ltd. and Sandoz International GmbH..

The Hydrocortisone Sodium Succinate market is projected to expand substantially, driven by escalating demand propels market and technological advancements in drug delivery systems. This growth is expected to be further supported by Industry trends like Expansion of market via Topical Applications.

Moreover, the key opportunities, such as expansion into untapped markets, innovation in drug delivery technologies and strategic collaborations for product development, are anticipated to create revenue pockets in major demand hubs including U.S., China, Germany, UK and Japan.

Regional Shifts and Evolving Supply Chains

North America and Asia Pacific are the two most active and leading regions in the market. With challenges like regulatory hurdles and production challenges, Hydrocortisone Sodium Succinate market’s supply chain from raw material procurement / api manufacturing / product synthesis to distribution & supply is expected to evolve & expand further; and industry players will make strategic advancement in emerging markets including India, Brazil and South Africa for revenue diversification and TAM expansion.

About DataString Consulting

DataString Consulting offers a complete range of market research and business intelligence solutions for both B2C and B2B markets all under one roof. We offer bespoke market research projects designed to meet the specific strategic objectives of the business. DataString’s leadership team has more than 30 years of combined experience in Market & business research and strategy advisory across the world. DataString Consulting’s data aggregators and Industry experts monitor high growth segments within more than 15 industries on an ongoing basis.

DataString Consulting is a professional market research company which aims at providing all the market & business research solutions under one roof. Get the right insights for your goals with our unique approach to market research and precisely tailored solutions. We offer services in strategy consulting, comprehensive opportunity assessment across various sectors, and solution-oriented approaches to solve business problems.

[vijay34]

Bio-based Succinic Acid Gains Traction Amid Sustainable Chemical Demand

Growing Demand for Bio-Based Chemicals and Versatile Industrial Applications Drives Growth in the Succinic Acid Market.

The Succinic Acid Marketsize was valued at USD 216.3 Million in 2023. It is expected to grow to USD 466.7 Million by 2032 and grow at a CAGR of 5.4% over the forecast period of 2024-2032.

The Succinic Acid Market is driven by its expanding use in diverse industries such as pharmaceuticals, food & beverages, polymers, and resins. Traditionally derived from petroleum, succinic acid is increasingly being produced through bio-based fermentation processes, making it a key component in the shift toward sustainable chemical production. As a versatile platform chemical, it plays a critical role in manufacturing biodegradable plastics, solvents, and specialty chemicals, aligning well with global sustainability goals.

Key Players

BASF SE

DuPont

GlaxoSmithKline

Jiangsu Sopo Chemical Co., Ltd.

Reverdia

Myriant Corporation

Lanxess AG

GFBiochemicals

Corbion

DSM

Future Scope & Emerging Trends

The succinic acid market is expected to expand significantly with increased investment in bio-refining technologies and the global push for low-carbon industrial solutions. An emerging trend is the production of bio-succinic acid, which offers a sustainable alternative to petroleum-derived variants and is gaining traction in packaging, automotive, and textile industries. Moreover, the development of new applications in biodegradable polybutylene succinate (PBS) plastics is unlocking potential in eco-friendly packaging. Asia-Pacific is projected to be the fastest-growing region, driven by industrial growth and increasing environmental regulations.

Key Points

Increasing demand for bio-based chemicals and green alternatives

Growing applications in polymers, resins, and solvents

Expanding role in biodegradable plastic production (PBS)

Strong growth in pharmaceutical and food additive segments

Rapid industrialization and regulatory support in Asia-Pacific

Conclusion

As industries around the globe move toward more sustainable practices, the Succinic Acid Market is emerging as a cornerstone in the bio-based chemicals sector. With innovation in production technologies and expanding end-use applications, succinic acid is well-positioned for long-term growth and environmental impact.

Read Full Report: https://www.snsinsider.com/reports/succinic-acid-market-4856     

Contact Us:

Jagney Dave — Vice President of Client Engagement

Phone: +1–315 636 4242 (US) | +44- 20 3290 5010 (UK)

[mordormr]

The Succinic Acid Industry: Market Trends, Growth Drivers, and Future Outlook

The Succinic Acid Market is projected to grow at a CAGR of 7.2% over the forecast period.

This blog explores the current trends, market drivers, challenges, and future outlook of the succinic acid industry.

Market Overview

The global succinic acid market has been expanding rapidly due to the growing shift toward bio-based chemicals and the rising demand for green alternatives to petrochemicals. Traditionally, succinic acid was produced from fossil fuel-based sources, but bio-based succinic acid has gained prominence as a sustainable and environmentally friendly alternative.

Market Drivers

Several factors are contributing to the increasing demand for succinic acid across industries:

1. Growing Demand for Bio-Based Chemicals

With rising environmental concerns and regulatory restrictions on petroleum-based chemicals, bio-based succinic acid is gaining traction. It serves as a sustainable alternative in industries such as biodegradable plastics and green solvents.

2. Expansion of the Pharmaceutical Industry

Succinic acid is widely used in the pharmaceutical sector as an intermediate for drug production. The increasing global demand for pharmaceutical products is boosting the consumption of succinic acid.

3. Rising Adoption in the Food and Beverage Industry

Succinic acid is used as an acidity regulator, flavor enhancer, and pH stabilizer in food and beverages. The growing demand for packaged food and beverages is driving its adoption.

4. Growing Demand in the Agriculture Sector

As a key ingredient in fertilizers and plant growth regulators, succinic acid plays a crucial role in agriculture. The increasing global population and the need for higher agricultural productivity are fueling its demand.

5. Increasing Use in Biodegradable Plastics

Succinic acid is used in the production of polybutylene succinate (PBS), a biodegradable plastic with applications in packaging, agriculture, and consumer goods. The global push toward reducing plastic waste is boosting the demand for PBS, subsequently driving succinic acid consumption.

Challenges in the Succinic Acid Market

Despite its growth potential, the succinic acid industry faces some challenges:

High Production Costs: The cost of producing bio-based succinic acid remains higher than its petrochemical counterpart, limiting its widespread adoption.

Technological Limitations: The scalability of bio-based succinic acid production needs further technological advancements to compete with traditional methods.

Regulatory Constraints: Compliance with environmental and safety regulations varies across regions, posing challenges for manufacturers.

Future Outlook

The succinic acid market is expected to witness sustained growth in the coming years due to technological advancements, increased R&D activities, and expanding applications. Some key trends that will shape the market include:

Advancements in Bio-Based Production: Continuous research in fermentation processes and biotechnology is expected to reduce production costs and enhance the efficiency of bio-based succinic acid production.

Government Initiatives for Sustainability: Policies supporting bio-based and biodegradable materials will drive demand for succinic acid in various industries.

Increased Investment in Green Technologies: Companies are increasingly investing in sustainable solutions, further fueling market expansion.

Growing Demand in Emerging Economies: Rapid industrialization and urbanization in countries like China, India, and Brazil are expected to boost the succinic acid market.

Conclusion

The succinic acid industry is poised for significant growth, driven by increasing demand for bio-based chemicals, expanding pharmaceutical and food industries, and rising adoption in biodegradable plastics. Despite challenges such as high production costs and regulatory complexities, advancements in technology and supportive government policies are expected to create new opportunities for market players.

Manufacturers and investors should focus on sustainability, research, and innovation to capitalize on the expanding market and contribute to the global shift toward eco-friendly chemical solutions.

[biology-geology-beaches-india]

The Science Research Notebooks of S. Sunkavally, p 663.

[mindblowingscience]

In a breakthrough for environmentally friendly chemical production, researchers at the Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) have developed an economical way to make succinic acid, an important industrial chemical, from sugarcane. The team of University of Illinois and Princeton University researchers created a cost-effective, end-to-end pipeline for this valuable organic acid by engineering a tough, acid-tolerant yeast as the fermenting agent, avoiding costly steps in downstream processing. Succinic acid is a widely used additive for food and beverages and has diverse applications in agricultural and pharmaceutical products. This same pipeline can be used to produce other industrially important organic acids targeted by CABBI in its work to develop sustainable biofuels and biochemicals from crops, said co-author Huimin Zhao, CABBI's Conversion Theme Leader and Professor of Chemical and Biomolecular Engineering (ChBE) at Illinois. To reduce reliance on fossil fuels, Conversion researchers are deploying microbes to convert plant biomass into chemicals used in everyday products as an alternative to conventional petroleum-based production.

Continue Reading

[centurypharma]

The critical regulatory processes and quality control measures that pharmaceutical manufacturers adhere to.